Suppression of Corneal Neovascularization and TGF-Beta Signal in Osteopontin-Null Mice

S. R. Rittling , D. T. Denhardt , S. Saika , N. Fujita
Investigative Ophthalmology & Visual Science 49 ( 13) 1482 -1482

2008
Loss of Osteopontin Perturbs the Epithelial-Mesenchymal Transition in an Injured Mouse Lens Epithelium

S. R. Rittling , D. T. Denhardt , S. Saika , S. Kon
Investigative Ophthalmology & Visual Science 48 ( 13) 2774 -2774

36
2007
The mitogen-regulated protein/proliferin transcript is degraded in primary mouse embryo fibroblast but not 3T3 nuclei: altered RNA processing correlates with immortalization.

U. M. Malyankar , S. R. Rittling , A. Connor , D. T. Denhardt
Proceedings of the National Academy of Sciences of the United States of America 91 ( 1) 335 -339

17
1994
Expression of cell cycle-dependent genes in young and senescent WI-38 fibroblasts.

S. R. Rittling , K. M. Brooks , V. J. Cristofalo , R. Baserga
Proceedings of the National Academy of Sciences of the United States of America 83 ( 10) 3316 -3320

209
1986
Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption

H. Yoshitake , S. R. Rittling , D. T. Denhardt , M. Noda
Proceedings of the National Academy of Sciences of the United States of America 96 ( 14) 8156 -8160

333
1999
Colocalization of Intracellular Osteopontin With CD44 Is Associated With Migration, Cell Fusion, and Resorption in Osteoclasts

K. Suzuki , B. Zhu , S. R. Rittling , D. T. Denhardt
Journal of Bone and Mineral Research 17 ( 8) 1486 -1497

130
2002
Osteopontin Deficiency Produces Osteoclast Dysfunction Due to Reduced CD44 Surface Expression

M. A. Chellaiah , N. Kizer , R. Biswas , U. Alvarez
Molecular Biology of the Cell 14 ( 1) 173 -189

203
2003
Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice

K. Yumoto , M. Ishijima , S. R. Rittling , K. Tsuji
Proceedings of the National Academy of Sciences of the United States of America 99 ( 7) 4556 -4561

189
2002
101
2007
43
1992
Regulatory mechanisms in the expression of cell cycle dependent genes.

S R Rittling , R Baserga
Anticancer Research 7 541 -552

13
1987
The synthesis and turnover of ferritin in rat L-6 cells. Rates and response to iron, actinomycin D, and desferrioxamine.

S R Rittling , R C Woodworth
Journal of Biological Chemistry 259 ( 9) 5561 -5566

20
1984
Osteopontin is required for full expression of the transformed phenotype by the ras oncogene

Y Wu , D T Denhardt , S R Rittling
British Journal of Cancer 83 ( 2) 156 -163

90
2000
Role of osteopontin in tumour progression

S R Rittling , A F Chambers
British Journal of Cancer 90 ( 10) 1877 -1881

605
2004
Functional analysis and growth factor regulation of the human vimentin promoter.

S R Rittling , R Baserga
Molecular and Cellular Biology 7 ( 11) 3908 -3915

86
1987
Suppression of tumour growth by orally administered osteopontin is accompanied by alterations in tumour blood vessels.

S R Rittling , P L Wejse , K Yagiz , G A Warot
British Journal of Cancer 110 ( 5) 1269 -1277

8
2014
Reduced tolerance to acute renal ischemia in mice with a targeted disruption of the osteopontin gene.

Eisei Noiri , Kate Dickman , Frederick Miller , Galina Romanov
Kidney International 56 ( 1) 74 -82

92
1999
CELL-CYCLE GENE-EXPRESSION IN YOUNG AND SENESCENT WI-38 CELLS

SR RITTLING , KM BROOKS , VJ CRISTOFALO , R BASERGA
FEDERATION PROCEEDINGS 45 ( 6) 1584 -1584

1986